Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07387445 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.
A NA study, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07387445 is a NA study that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 40 participants.
The verdict
NCT07387445, a NA study, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is being done to better understand how time restricted eating (eating all food in an 8 hour window) can help a person receiving chemotherapy treatment for breast cancer, stages I-IV. The aim is to find out if time restricted is feasible and acceptable to individuals starting chemotherapy for breast cancer. We will test 3 different eating window options compared to a control group for 24 weeks.
Interventions
- BEHAVIORAL Time restricted eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07387445
The ClinicalTrials.gov registry entry for NCT07387445 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Time restricted eating is the first listed.
NCT07387445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07387445 about?
NCT07387445 is a clinical study titled "Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.". This study is being done to better understand how time restricted eating (eating all food in an 8 hour window) can help a person receiving chemotherapy treatment for breast cancer, stages I-IV. The aim is to find out if time restricted is feasible and acceptable to individuals starting chemotherapy ...
What is the current status of trial NCT07387445?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07387445?
The interventions under investigation include: Time restricted eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT07387445?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.